Our findings of a critical role of the C5a/C5aR pathways as drivers of skin pathology in EBA are in line with results from obtained in experimental models of other AIBDs such as BP or mucus membrane pemphigoid. This evidence concerns the gene C5 and acquired epidermolysis bullosa.